TIAA CREF INVESTMENT MANAGEMENT LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 140 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$245,000
+35.4%
52,971
+2.3%
0.00%
Q4 2018$181,000
-83.1%
51,777
-51.1%
0.00%
Q3 2018$1,068,000
+170.4%
105,926
+94.1%
0.00%
Q2 2018$395,000
+16.9%
54,582
-2.6%
0.00%
Q1 2018$338,000
-43.8%
56,028
-10.3%
0.00%
Q4 2017$601,000
+5.6%
62,480
-2.4%
0.00%
Q3 2017$569,000
-29.8%
64,0480.0%0.00%
-100.0%
Q2 2017$810,000
+24.8%
64,048
+3.6%
0.00%
Q1 2017$649,000
+9.8%
61,798
-3.8%
0.00%
Q4 2016$591,000
-27.8%
64,208
-7.6%
0.00%
-100.0%
Q3 2016$819,000
-11.5%
69,469
-2.8%
0.00%0.0%
Q2 2016$925,000
-48.4%
71,454
-36.2%
0.00%0.0%
Q1 2016$1,792,000
-80.9%
112,063
-65.7%
0.00%
-85.7%
Q4 2015$9,364,000
-1.2%
327,060
-1.8%
0.01%0.0%
Q3 2015$9,476,000
-26.5%
332,968
-7.2%
0.01%
-22.2%
Q2 2015$12,893,000
-3.9%
358,950
+55.6%
0.01%0.0%
Q1 2015$13,411,000
+785.2%
230,705
+542.1%
0.01%
+800.0%
Q4 2014$1,515,000
+5.9%
35,932
-2.6%
0.00%0.0%
Q3 2014$1,430,000
+19.0%
36,882
-4.2%
0.00%0.0%
Q2 2014$1,202,000
-9.5%
38,501
+20.1%
0.00%0.0%
Q1 2014$1,328,000
+41.1%
32,049
+31.8%
0.00%0.0%
Q4 2013$941,000
+62.8%
24,316
+47.3%
0.00%
Q3 2013$578,000
+186.1%
16,506
+12.9%
0.00%
Q2 2013$202,00014,6160.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders